Location History:
- Calcutta, IN (2003 - 2011)
- West Bengal, IN (2015)
- Kolkata, IN (2002 - 2016)
Company Filing History:
Years Active: 2002-2016
Title: Santu Bandyopadhyay: Innovator in Cancer and Asthma Treatment
Introduction
Santu Bandyopadhyay is a prominent inventor based in Kolkata, India. He has made significant contributions to the fields of cancer and asthma treatment through his innovative research and development. With a total of 17 patents to his name, Bandyopadhyay continues to push the boundaries of medical science.
Latest Patents
One of his latest patents is a high affinity bivalent helically constrained peptide against cancer. This invention describes a novel bivalent helically constrained peptide targeted against S100B, which serves as an effective anti-cancer drug for cancers that over-express S100B. The helix mimetic targeted against S100B induces rapid apoptosis in cancer cells by simultaneously inhibiting key growth pathways, including the activation of p53.
Another significant patent involves substituted catechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma. This invention relates to compounds designed to treat bronchial asthma by inhibiting the IL-4 or IL-5 pathways. The method of treating asthma involves administering the compound through oral, intranasal routes, or by inhalation to a mammal in need. The compound may also be used to reduce perivascular and peribronchial inflammation.
Career Highlights
Santu Bandyopadhyay is associated with the Council of Scientific & Industrial Research, where he conducts his research and development activities. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Bandyopadhyay has collaborated with notable colleagues, including Keshab Chandra Roy and Bikash Chandra Pal. Their combined expertise has contributed to the advancement of innovative solutions in their respective fields.
Conclusion
Santu Bandyopadhyay stands out as a key figure in the realm of medical innovation, particularly in cancer and asthma treatment. His patents reflect a commitment to improving health outcomes through scientific research and collaboration.